Convenio Oncológico FALP

What Convenio Oncológico FALP does

Convenio Oncológico FALP is the solidarity-based oncology coverage plan operated by Fundación Arturo López Pérez (FALP), a private non-profit foundation headquartered in Santiago, Chile. FALP runs a comprehensive oncology platform through its Instituto Oncológico, delivering prevention, screening, diagnosis, treatment, rehabilitation, and palliative care across more than 25 specialized clinical units. Its two principal Santiago facilities are located at José Manuel Infante 805 (Providencia) and Antonio Varas 621, and the foundation serves more than 11,000 new cancer patients annually, including both Chilean residents and international patients. The Convenio Oncológico plan is sold to individuals and to corporate/institutional groups (Plan Colectivo) and provides subscribers structured access to FALP's diagnostic and treatment services.

The foundation's revenue model rests on three streams: recurring Convenio Oncológico subscriptions, fee-for-service clinical revenue from direct patient care, and donations from individuals and corporate partners. FALP supplements its clinical operations with adjacent social services such as the Casa de Acogida patient lodging facility, a tumor biobank, and epidemiological research programs. The organization holds OECI (Organisation of European Cancer Institutes) accreditation, recognition from the Chilean Superintendencia de Salud, Propyme certification, and UICC membership, positioning it as one of the few Chilean centers operating to international oncology standards and as a reference employer of the country's oncology workforce, more than 75% of which is concentrated in the Santiago metropolitan region.

Technologically, FALP has begun integrating artificial intelligence into its diagnostic workflow, most visibly through the June 2026 launch of AI-assisted contrast mammography for breast lesion detection, and has extended clinical reach through a telemedicine channel. A June 2026 partnership with Pontificia Universidad Católica de Valparaíso (PUCV) targets oncology research and care capacity expansion into Chile's Valparaíso (V) Region, signaling a strategic move beyond the Santiago metro base.

Name

Convenio Oncológico FALP

Legal name

Fundación Arturo López Pérez

Website

https://institutoncologicofalp.cl

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

FALP (Fundación Arturo López Pérez) is a Chilean non-profit operating a comprehensive oncology platform through its Instituto Oncológico in Santiago. It serves 11,000+ cancer patients annually via subscription-based Convenio Oncológico coverage, fee-for-service care, donations, and telemedicine across two facilities.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology Telemedicine Platforms (HLALAGAH), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Cancer treatment services
• Oncology diagnostics
• Radiation therapy
• Palliative care
• Cancer insurance plans

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. Convenio Oncológico (Collective Cancer Coverage Plan): The flagship revenue stream: a solidarity-based cancer coverage plan sold to enterprises and institutions (Plan Colectivo), providing enrolled members with diagnostic and treatment coverage. Revenue is generated through recurring premiums paid by employer/institutional subscribers.
2. Direct Patient Services (Fee-for-Service): Fee-for-service payments from individual patients for consultations, diagnostics, chemotherapy, radiotherapy, surgery, and other oncological treatments. Includes international patient services.
3. Donations and Philanthropy: Charitable donations received through the FALP donations portal, supporting social programs including patient lodging (Casa de Acogida FALP), mammography screenings, nutritional support, and treatment financing for underprivileged patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

Core offering

Convenio Oncológico FALP is a solidarity-based collective cancer coverage plan sold to enterprises and institutions, paired with the comprehensive in-house clinical platform of Fundación Arturo López Pérez (FALP). It provides enrolled members and the broader public with end-to-end oncological care — prevention, diagnosis (imaging, pathology, nuclear medicine), oncological surgery, chemotherapy, advanced radiotherapy, palliative care, follow-up, and patient/family support services — delivered at the Instituto Oncológico and Centro de Oncología Ambulatoria in Santiago and supplemented by telemedicine, a tumor biobank, clinical trials, and the Casa de Acogida lodging program.

Product overview

Convenio Oncológico FALP operates as part of Fundación Arturo López Pérez, a comprehensive oncology institute and foundation in Chile. The core offering is the Convenio Oncológico FALP (FALP Oncology Agreement), a solidarity-based cancer coverage plan that provides members with access to integrated cancer diagnosis and treatment services. The organization functions as a platform-plus-services model, combining the insurance/coverage product (Convenio Oncológico) with a network of clinical services including oncological surgery, chemotherapy, advanced radiotherapy, nuclear medicine, palliative care, and follow-up programs. Diagnostic capabilities are provided through anatomical pathology, clinical laboratory, medical imaging, endoscopy, and interventional radiology. The ecosystem also includes prevention programs (FALP Onco Control), telemedicine access, patient support services (accommodation at Casa de Acogida, mental health unit, complementary therapies), and research programs including clinical trials and a tumor biobank.

Differentiator

Problem solved

Functional benefit

Products and services

• Convenio Oncológico FALP (Plan Colectivo)

Quantifiable outcome

• Over 11,000 cancer diagnoses per year managed at FALP facilities
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature24 records

Partnerships

One partnership is on record.

• Pontificia Universidad Católica de Valparaíso (PUCV)coreStrategic or Co-development Partner · 22 June 2026FALP and PUCV entered a joint research collaboration aimed at strengthening oncological diagnosis and treatment in Chile's V Region (Valparaíso region). The partnership involves researchers from PUCV's Center of Investigation visiting FALP to advance shared initiatives in cancer care, reflecting a mutual commitment to expanding oncology research and access outside the Santiago metropolitan area.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Clínica Alemana de Santiago: Major Santiago private hospital with oncology service line competing for the same Chilean patient base — a domestic competitor operating in the same market with overlapping capabilities.
• Hospital Italiano de Buenos Aires: Argentine academic hospital with a strong oncology program, research infrastructure, and a hybrid public-private funding model — a Southern Cone peer with overlapping comprehensive-care and research capabilities.
• Clínica Universidad Católica de Chile: Chilean academic hospital offering oncology services with university research affiliations — a Santiago-based peer with overlapping clinical and academic activities in the same domestic market.

Broad incumbents

• Gustave Roussy: European comprehensive cancer center and OECI member offering integrated clinical care, research, and teaching — directly comparable international peer sharing OECI accreditation and full-spectrum service model.
• MD Anderson Cancer Center: Global leader in comprehensive cancer care, research, and clinical trials — a broader incumbent operating at much greater scale with comparable service-line breadth and research infrastructure.
• Memorial Sloan Kettering Cancer Center: US-based comprehensive cancer center with deep research and biobank capabilities — a global incumbent that anchors the upper bound of FALP's aspirational positioning.
• European Institute of Oncology (IEO): Milan-based European cancer institute specializing in oncology diagnosis, treatment, and research — comparable European peer with strong domain specialization in cancer care.

Direct peers

• A.C. Camargo Cancer Center: A.C. Camargo is a São Paulo-based comprehensive cancer center combining hospital care, research, and teaching — directly comparable to FALP's model of integrated oncology services plus biobank/clinical trials.
• Hospital de Câncer de Barretos: Brazilian cancer hospital funded largely by philanthropy and operating a national referral network plus research programs — a non-profit cancer institute with comparable social-health model.
• Instituto Nacional de Cancerología (Colombia): Colombia's national cancer institute provides comprehensive oncological care, research, and public-health functions across the full cancer continuum — a Latin American public-sector peer with similar service breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights1 record

Customer concentration

• YouTubeyoutube.com/channel/UCGX-UzlC9XC7Rvv-GxLeWmQ/videos
• Facebookfacebook.com/Falpcomunicaciones
• LinkedInlinkedin.com/company/institutoncologicofalp
• Instagraminstagram.com/falpfundacion
• TikToktiktok.com/discover/falp-fundacion

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Convenio Oncológico FALP